Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Speciality Chemicals	22.14B	20.61B	18.49B	19.81B	17.24B
Nutrition & Health Solutions	7.90B	7.48B	6.80B	5.51B	7.67B
Inter Segment Revenue	-2.85B	-2.53B	-2.90B	-2.26B	-4.76B
Chemical Intermediates	16.68B	16.22B	18.97B	24.66B	29.34B
Total	43.88B	41.78B	41.36B	47.73B	49.49B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
India	24.79B	22.60B	24.43B	27.11B	31.61B
Americas and Europe	14.07B	14.93B	12.97B	14.68B	13.06B
China	1.71B	1.18B	1.24B	2.69B	1.68B
Rest of The World	3.31B	3.07B	2.72B	3.25B	3.15B
Total	43.88B	41.78B	41.36B	47.73B	49.49B

Data Source: S&P Global Market Intelligence Last updated: Jul 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error